Google has officially merged Bard with DeepMind’s cutting-edge research—and the result is a new era of AI capability. In this ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Google DeepMind CEO Demis Hassabis heads Gemini and the company's AI push while gaining more power. Here's how he became ...

After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

This AI system can analyze up to one million DNA letters at once, predicting how tiny changes in noncoding regions trigger ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...

Activists staged a mock courtroom outside Google DeepMind, accusing the tech giant of backtracking on its AI safety pledge ...

(Reuters) -Google has hired Windsurf CEO Varun Mohan, co-founder Douglas Chen, and select members of the coding tool's ...

Google DeepMind's drug discovery arm, Isomorphic Labs, is almost ready to begin human trials of its AI-designed drugs.In an interview with Fortune, Colin Murdoch, President of Isomorphic Labs and ...